| Natera, Inc. Common Stock | $56.0b | $279.89 | -2.9% | 881.1K | |
| Guardant Health, Inc. Common Stock | $23.5b | $142.45 | -1.2% | 766.5K | |
| Caris Life Sciences, Inc. Common Stock | $9.3b | $19.93 | -4.8% | 1.6M | |
| GRAIL, Inc. Common Stock | $6.2b | $100.66 | -4.2% | 241.2K | |
| BillionToOne, Inc. Class A Common Stock | $5.2b | $96.88 | +0.2% | 332.2K | |
| Adaptive Biotechnologies Corporation Common Stock | $4.1b | $28.02 | +0.3% | 728.6K | |
| Veracyte, Inc. | $4.0b | $23.73 | -1.1% | 541.8K | |
| NeoGenomics, Inc. | $2.2b | $15.09 | -2.3% | 313.9K | |
| Personalis, Inc. Common Stock | $1.7b | $14.57 | -1.4% | 1.4M | |
| Castle Biosciences, Inc. Common Stock | $1.1b | $33.25 | +1.3% | 97.0K | |
| Myriad Genetics Inc | $0.6b | $5.46 | -1.7% | 308.6K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $23.73 | -2.0% | 73.8K | |
| The Oncology Institute, Inc. Common Stock | $0.5b | $5.19 | 0.0% | N/A | |
| AngioDynamics, Inc. | $493.3m | $11.48 | -2.8% | 65.3K | |
| Biodesix, Inc. Common Stock | $222.1m | $8.88 | -0.2% | 53.2K | |
| Lucid Diagnostics Inc. Common Stock | $78.1m | $0.39 | -1.3% | 683.5K | |
| Quantum Cyber N.V. Ordinary Shares | $60.8m | $0.56 | 0.0% | 78.9K | |
| Sensus Healthcare, Inc | $54.1m | $2.29 | -6.8% | 116.6K | |
| Precipio, Inc. Common Stock | $33.3m | $19.03 | 0.0% | 25.2K | |
| MDxHealth SA Ordinary Shares | $15.1m | $0.15 | +1.9% | 126.5K | |
| PAVmed Inc. Common Stock | $14.6m | $1.74 | 0.0% | 11.2K | |
| VolitionRx Limited | $5.8m | $0.20 | -2.7% | 2.1M | |
| Zhongchao Inc. Class A Ordinary Shares | $4.4m | $0.87 | -3.1% | 37.6K | |
| Advanced Biomed Inc. Common Stock | $3.6m | $2.18 | 0.0% | 12.9K | |
| Avalon GloboCare Corp. Common Stock | $3.5m | $0.28 | 0.0% | N/A | |
| Onconetix, Inc. Common Stock | $3.3m | $2.91 | 0.0% | 12.9K | |
| 20/20 Biolabs, Inc. Common Stock | $3.0m | $0.18 | 0.0% | 130.4K | |
| bioAffinity Technologies, Inc. Common Stock | $1.9m | $2.00 | +1.0% | 27.9K |